Arthritis: Out-of-Pocket Arthritis Costs Rising Despite Medicare Drug Benefit
Out-of-pocket medical costs for Medicare-age adults were brought close to 2003 levels by the new Medicare Part D drug benefit, but high OTC and prescription costs continue to be an issue...
Autoimmunity: "Good Bugs" Offer New Way to Turn Down Inflammatory Response
"Probiotic" helpful bacteria might be able to turn down the body's inflammatory response...
Consumer News: Scientists Discover How Osteoarthritis Destroys Cartilage
New discovery may lead to preventive treatment for osteoarthritis...
BioPharm Business: Omeros Enters Into Agreement With Affitech for Anti-inflammatory Therapeutics, Awaits Phase III Clinical Trial Results for Agent
Omeros Corp and Affitech AS have entered into an agreement for the discovery and development of fully human antibodies for Omeros' MASP-2, which mediates activation of the complement system via the lectin pathway...
|